Novo Nordisk's new chief executive, Mike Doustdar, has told the JPM Healthcare conference that the key to competing in the GLP-1 agonist category for weight loss will be to make the most of cash-pay ...
A while ago I wrote about a financial gift that my parents made to my husband and me shortly after our marriage. While it wasn’t a huge sum of money, it helped us purchase a better first home than we ...